KLDO (Kaleido Biosciences) Total Operating Expense: $88.77 Mil (TTM As of Dec. 2021)


What is Kaleido Biosciences Total Operating Expense?

Kaleido Biosciences KLDO -99.00% Total Operating Expense is $88.77 Mil as of Dec. 2021.

Kaleido Biosciences's Total Operating Expense for the three months ended in Dec. 2021 was $20.19 Mil. Kaleido Biosciences's Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2021 was $88.77 Mil.

Kaleido Biosciences Total Operating Expense Related Terms

Kaleido Biosciences Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Kaleido Biosciences's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kaleido Biosciences Total Operating Expense Chart

Kaleido Biosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Total Operating Expense
Get a 7-Day Free Trial 27.03 60.68 86.66 79.85 88.77

Kaleido Biosciences Quarterly Data
Dec16 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.54 22.65 23.42 22.52 20.19

Kaleido Biosciences Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $88.77 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $88.77 Mil mean?
Kaleido Biosciences (KLDO) has a Total Operating Expense of $88.77 Mil as of Dec. 2021. Total operating expense is the primary recurring expense associated with central operations. View historical data on Kaleido Biosciences and its competitors.
Is Kaleido Biosciences' Total Operating Expense too high?
Kaleido Biosciences' current Total Operating Expense is $88.77 Mil.
How does Kaleido Biosciences' Total Operating Expense compare to NPTX and GSTC?
Kaleido Biosciences' Total Operating Expense of $88.77 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Biotechnology company?
A good Total Operating Expense depends on the Biotechnology industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Kaleido Biosciences and its competitors. Kaleido Biosciences's current Total Operating Expense is $88.77 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kaleido Biosciences stock overvalued right now?
Kaleido Biosciences (KLDO) has a current Total Operating Expense of $88.77 Mil. The current Total Operating Expense is $88.77 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Kaleido Biosciences (KLDO), the current Total Operating Expense is $88.77 Mil as of Dec. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kaleido Biosciences Business Description

Address 65 Hayden Avenue, Lexington, MA, USA, 02421
Kaleido Biosciences Inc is a clinical-stage healthcare company. It is focused on leveraging the potential of the microbiome organ to treat disease and improve human health. Its product candidates are Microbiome Metabolic Therapies, or MMTs, which are designed to modulate the metabolic output and profile of the microbiome.